other material
confidence high
sentiment negative
materiality 0.70
Lexicon shareholders approve reverse stock split authorization (1:10-1:50) and increase equity plan share reserves
LEXICON PHARMACEUTICALS, INC.
- Shareholders approved reverse stock split at ratio 1-for-10 to 1-for-50, at board discretion before 2026 annual meeting.
- Equity incentive plan shares increased from 55M to 75M; Non-Employee Directors plan from 2M to 4M.
- Directors Raymond Debbane and Ivan H. Cheung elected with >205M and >226M votes for, respectively.
- Ernst & Young ratified as independent auditor for FY 2025.
- Advisory vote on executive compensation approved with 220.5M for, 7.9M against.